Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-16
INCYIncyte CorpFriedman Paul ADirS - Sale$105.24-28,507269,011-10%-$3,000,077
2017-11-14
TENXTenax Therapeutics, Inc.Blanck Ronald RDirS - Sale$0.39-12,9507,149-64%-$5,051
D
2017-11-15
IQVIqvia Holdings Inc.Erlinger III James HSee RemarksS - Sale+OE$102.17-10,00017,340-37%-$1,021,700
2017-11-16
PRAHPra Health Sciences, Inc.Young Matthew P.DirS - Sale$79.90-5,1152,810-65%-$408,689
2017-11-13
XONIntrexon CorpLast Andrew J.COOP - Purchase$12.10+2,0004,000+100%+$24,200
D
2017-11-09
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$59.14-137,805920,231-13%-$8,149,669
D
2017-11-06
QIqvia Holdings Inc.Greenberg Jack MDirS - Sale+OE$108.07-33,40030,316-52%-$3,609,388
2017-11-01
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$36.50-9,0005,751,5220%-$328,500
D
2017-11-01
QQuintiles Ims Holdings, Inc.Bousbib AriSee RemarksS - Sale+OE$108.14-46,0801,534,061-3%-$4,983,091
2017-11-01
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$53.60-45,775251,733-15%-$2,453,768
2017-11-02
INCYIncyte CorpGryska David WEVP, CFOS - Sale$105.63-3,91513,992-22%-$413,541
M
2017-10-26
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-18,1955,760,5220%-$691,442
2017-10-25
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.39+3751,012,2500%+$1,646
M
2017-10-23
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$38.00-2,3945,778,7170%-$90,972
2017-10-24
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.92+3751,011,8750%+$1,845
M
2017-10-19
NRCIANational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$37.01-110,1445,781,111-2%-$4,076,520
D
2017-10-18
QQuintiles Ims Holdings, Inc.Erlinger III James HSee RemarksS - Sale+OE$100.51-10,00017,340-37%-$1,005,100
2017-10-19
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.49+3751,011,5000%+$1,684
2017-10-17
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.27+3751,011,1250%+$1,601
2017-10-13
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.22+7501,010,7500%+$3,165
D
2017-10-05
CRLCharles River Laboratories International IncJohst David PCorporate EVPS - Sale+OE$110.00-24,759181,255-12%-$2,723,490
D
2017-10-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$110.00-6,16563,566-9%-$678,150
2017-10-05
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.30+3751,010,0000%+$1,613
D
2017-10-02
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$47.16-81,025297,508-21%-$3,820,734
D
2017-10-02
EXASExact Sciences CorpCoward D ScottSVP, GCS - Sale+OE$47.16-29,11539,239-43%-$1,373,115
D
2017-10-02
QQuintiles Ims Holdings, Inc.Bousbib AriSee RemarksS - Sale+OE$94.91-46,0801,534,061-3%-$4,373,453
2017-10-02
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.20+3751,009,6250%+$1,575
D
2017-09-27
QQuintiles Ims Holdings, Inc.Erlinger III James HSee RemarksS - Sale+OE$94.52-10,00017,340-37%-$945,200
2017-09-28
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.21+3751,009,2500%+$1,579
DM
2017-09-27
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale+OE$24.28-27,302268,260-9%-$663,018
DM
2017-09-26
EXELExelixis, Inc.Schwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.79-100,000197,191-34%-$2,378,667
2017-09-26
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$3.88+3751,008,8750%+$1,455
2017-09-22
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale$25.40-10,0001,034,314-1%-$254,000
2017-09-19
QQuintiles Ims Holdings, Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$94.87-6,748,02613,049,669-34%-$640,185,227
2017-09-19
QQuintiles Ims Holdings, Inc.Danhakl John GDirS - Sale$94.87-720,2484,176,443-15%-$68,329,928
2017-09-19
QQuintiles Ims Holdings, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Dir, 10%S - Sale$94.87-4,877,97428,285,500-15%-$462,773,393
2017-09-19
QQuintiles Ims Holdings, Inc.Connaughton JohnDirS - Sale$94.87-1,030,4296,682,534-13%-$97,756,799
M
2017-09-18
EXELExelixis, Inc.Papadopoulos SteliosDirS - Sale$27.68-200,0001,044,314-16%-$5,535,387
2017-09-20
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.23+3751,008,5000%+$1,586
2017-09-18
INCYIncyte CorpHoppenot HerveCOB , CEOS - Sale$119.45-70,502299,004-19%-$8,421,464
2017-09-18
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale$54.55-4,68255,897-8%-$255,427
2017-09-18
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale$54.48-9,70378,593-11%-$528,600
2017-09-18
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale$54.60-2,34899,453-2%-$128,201
2017-09-18
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.40+3751,008,1250%+$1,650
2017-09-14
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$27.21-60,64075,046-45%-$1,650,014
2017-09-14
INCYIncyte CorpFlannelly Barry PEVP, GM USS - Sale$124.25-71414,782-5%-$88,715
M
2017-09-12
EXELExelixis, Inc.Willsey LanceDirS - Sale$26.88-100,000468,273-18%-$2,688,000
D
2017-09-12
EXELExelixis, Inc.Senner Christopher J.EVP, CFOS - Sale+OE$26.79-100,000104,798-49%-$2,679,000
DM
2017-09-12
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$26.90-300,000249,718-55%-$8,071,000
2017-09-14
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.58+3751,007,7500%+$1,718
2017-09-11
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.81+3751,007,3750%+$1,804
2017-09-07
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.76+3751,007,0000%+$1,785
2017-09-08
INCYIncyte CorpBaker Bros. Advisors LPDir, 10%P - Purchase$132.00+100,000942,507+12%+$13,200,000
2017-09-08
BASIBioanalytical Systems IncNeff R MatthewDirP - Purchase$1.50+5,00010,000+100%+$7,500
D
2017-09-05
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale+OE$40.81-75,683343,283-18%-$3,088,801
D
2017-09-05
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$138.41-3,00026,706-10%-$415,230
2017-09-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale$108.43-2,66863,566-4%-$289,297
2017-09-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale$108.06-5,88919,217-23%-$636,347
D
2017-09-05
CRLCharles River Laboratories International IncMolho DavideCorporate EVPS - Sale+OE$107.55-5,98225,106-19%-$643,373
D
2017-09-01
QQuintiles Ims Holdings, Inc.Bousbib AriSee RemarksS - Sale+OE$95.65-46,0801,534,061-3%-$4,407,552
D
2017-09-01
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale+OE$58.99-88,73988,296-50%-$5,234,321
AD
2017-08-30
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale+OE$58.26-41,42078,296-35%-$2,413,230
D
2017-09-01
INCYIncyte CorpSiegel Eric H.EVP, GCS - Sale+OE$137.40-1,82021,733-8%-$250,068
D
2017-08-31
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$140.00-20,00035,067-36%-$2,800,000
2017-09-01
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$41.49-45,775300,966-13%-$1,899,205
D
2017-09-01
INCRInc Research Holdings, Inc.Gaenzle Christopher LCAO, GC, SecS - Sale+OE$58.67-42,60164,824-40%-$2,499,348
2017-09-05
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.90+3751,006,6250%+$1,838
D
2017-08-30
INCRInc Research Holdings, Inc.Rush Gregory SCFOS - Sale+OE$58.26-41,4207,290-85%-$2,413,230
D
2017-08-29
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale+OE$125.00-2,11118,165-10%-$263,875
2017-08-31
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.48+3751,006,2500%+$1,680
2017-08-28
QQuintiles Ims Holdings, Inc.Danhakl John GDirS - Sale$97.33-556,9684,896,691-10%-$54,209,695
2017-08-28
QQuintiles Ims Holdings, Inc.Gillings Dennis B Ph DDirS - Sale$97.33-968,0239,155,906-10%-$94,217,679
2017-08-28
QQuintiles Ims Holdings, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.Dir, 10%S - Sale$97.33-3,772,13433,163,474-10%-$367,141,802
2017-08-28
QQuintiles Ims Holdings, Inc.Connaughton JohnDirS - Sale$97.33-833,9047,834,970-10%-$81,163,876
2017-08-28
QQuintiles Ims Holdings, Inc.Cpp Investment Board Private Holdings, Inc.10%S - Sale$97.33-5,218,24515,299,011-25%-$507,891,786
2017-08-28
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.44+3751,005,8750%+$1,665
D
2017-08-25
QQuintiles Ims Holdings, Inc.Erlinger III James HSee RemarksS - Sale+OE$98.96-10,00017,340-37%-$989,600
D
2017-08-25
QQuintiles Ims Holdings, Inc.Knightly Kevin CSee RemarksS - Sale+OE$99.51-19,33924,351-44%-$1,924,429
D
2017-08-17
USRMU.S. Stem Cell, Inc.Murphy William P JrDirP - Purchase$0.03+1,799,6145,112,600+54%+$49,849
2017-08-24
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.54+3751,005,5000%+$1,703
2017-08-22
XONIntrexon CorpGupta Vinita DDirP - Purchase$17.61+3,0005,839+106%+$52,830
2017-08-22
XONIntrexon CorpShapiro Robert BDirP - Purchase$17.50+2,850126,123+2%+$49,883
2017-08-18
BASIBioanalytical Systems IncDavis Gregory ColeDirP - Purchase$1.70+5,0005,000New+$8,500
2017-08-18
BASIBioanalytical Systems IncNeff R MatthewDirP - Purchase$1.70+5,0005,000New+$8,500
2017-08-22
MEDPMedpace Holdings, Inc.Medpace Limited Partnership10%S - Sale$30.27-2,000,00020,999,997-9%-$60,540,000
2017-08-21
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$4.07+3751,005,1250%+$1,526
D
2017-08-17
INCRInc Research Holdings, Inc.Macdonald AlistairCEOS - Sale+OE$55.65-8,828101,801-8%-$491,261
2017-08-17
CRLCharles River Laboratories International IncBarbo William DCorporate EVP, CCOS - Sale$99.91-4,00016,924-19%-$399,632
2017-08-18
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$3.81+3751,004,7500%+$1,429
2017-08-17
EXASExact Sciences CorpCarey Thomas D.DirP - Purchase$37.71+2,50060,858+4%+$94,275
2017-08-17
PIRSPieris Pharmaceuticals, Inc.Geraghty James ADirP - Purchase$4.82+10,00010,000New+$48,200
M
2017-08-16
PIRSPieris Pharmaceuticals, Inc.Reine AllanSee RemarksP - Purchase$4.82+65,00065,000New+$313,350
2017-08-14
PRAHPra Health Sciences, Inc.Kkr Pra Investors L.P.10%S - Sale$74.85-9,500,00013,195,984-42%-$711,075,000
2017-08-14
PRAHPra Health Sciences, Inc.Shannon ColinPres, CEOS - Sale$74.85-400,0000-100%-$29,940,000
2017-08-14
PRAHPra Health Sciences, Inc.Baddour LindaEVP, CFOS - Sale$74.85-100,0000-100%-$7,485,000
D
2017-08-14
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale+OE$67.10-2,55211,671-18%-$171,228
2017-08-11
XONIntrexon CorpKindler Jeffrey BDirP - Purchase$18.32+5,44071,762+8%+$99,661
2017-08-14
XONIntrexon CorpLast Andrew J.COOP - Purchase$19.99+2,0002,000New+$39,980
2017-08-11
CASCCascadian Therapeutics, Inc.Myers Scott DunsethPres, CEOP - Purchase$3.73+5,50049,716+12%+$20,543
2017-08-14
AVXLAnavex Life Sciences Corp.Missling Christopher UPres, CEOP - Purchase$3.70+3751,004,3750%+$1,388

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top